ArticleScience progress
Hypoglycemic agents and contrast-induced acute kidney injury in type 2 diabetes: A retrospective cohort study of patients undergoing coronary angiography or percutaneous coronary intervention.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo investigate the association between different classes of hypoglycemic agents and the occurrence of contrast-induced acute kidney injury (CIAKI) in patients with type 2 diabetes mellitus (T2DM) undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI).MethodsThis retrospective cohort study included 2082 patients with T2DM who underwent CAG or PCI at two tertiary hospitals between January 2020 and December 2022. Patients were categorized into CIAKI and non-CIAKI groups, and baseline characteristics and short-term in-hospital outcomes were compared. The effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) use and other classes of glucose-lowering agents on the incidence of CIAKI were evaluated. Multivariable logistic regression analysis was performed to identify factors associated with the occurrence of CIAKI. Propensity score matching was further applied to assess the associations between different glucose-lowering agents and CIAKI as well as adverse cardiovascular outcomes.ResultsThe incidence of CIAKI was 11.7% (244/2082). Patients with CIAKI had significantly worse short-term in-hospital outcomes. In multivariable logistic regression analysis, SGLT2i use (OR = 1.892,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.